SC
LLY icon

Solstein Capital’s Eli Lilly LLY Stock Holding History

Solstein Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Sell
1,355
-150
-10% -$152K 0.51% 50
2025
Q4 		$1.62M Sell
1,505
-11
-0.7% -$10.5K 0.65% 37
2025
Q3 		$1.16M Hold
1,516
– – 0.26% 46
2025
Q2 		$1.18M Buy
1,516
+140
+10% +$109K 0.61% 40
2025
Q1 		$1.14M Sell
1,376
-80
-5% -$66.6K 0.66% 37
2024
Q4 		$1.12M Hold
1,456
– – 0.63% 43
2024
Q3 		$1.29M Sell
1,456
-93
-6% -$83.6K 0.68% 37
2024
Q2 		$1.4M Sell
1,549
-74
-5% -$59.2K 0.92% 30
2024
Q1 		$1.26M Sell
1,623
-11
-0.7% -$7.83K 0.88% 29
2023
Q4 		$952K Hold
1,634
– – 0.7% 36
2023
Q3 		$878K Hold
1,634
– – 0.75% 38
2023
Q2 		$766K Buy
1,634
+74
+5% +$31K 0.64% 41
2023
Q1 		$536K Sell
1,560
-575
-27% -$194K 0.47% 46
2022
Q4 		$781K Buy
2,135
+691
+48% +$245K 0.65% 37
2022
Q3 		$467K Hold
1,444
– – 0.41% 54
2022
Q2 		$468K Hold
1,444
– – 0.36% 58
2022
Q1 		$414K Buy
1,444
+661
+84% +$170K 0.27% 80
2021
Q4 		$216K Sell
783
-122
-13% -$30.9K 0.13% 124
2021
Q3 		$209K Hold
905
– – 0.12% 129
2021
Q2 		$208K Buy
905
+530
+141% +$106K 0.26% 94
2021
Q1 		$70K Buy
+375
New +$73.4K 0.1% 179
2020
Q4 		– Sell
-319
Closed -$47K – 155
2020
Q3 		$47K Hold
319
– – 0.11% 134
2020
Q2 		$52K Hold
319
– – 0.12% 112
2020
Q1 		$44K Buy
319
+61
+24% +$8.38K 0.17% 89
2019
Q4 		$34K Buy
+258
New +$29.9K 0.07% 137

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Solstein Capital's LLY Position: Q1 2026 in Review

Solstein Capital reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $152K and leaving 1,355 shares worth $1.25M. The position accounts for 0.51% of the portfolio, ranked #50.

Solstein Capital first reported a position in LLY in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.62M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Solstein Capital held 1,355 shares of Eli Lilly worth $1.25M as of Q1 2026.
  • Solstein Capital sold 150 Eli Lilly shares in Q1 2026, an estimated $152K.
  • Eli Lilly made up 0.51% of Solstein Capital's portfolio in Q1 2026, its #50 holding.
  • Solstein Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 25 quarters since.
  • Solstein Capital's Eli Lilly position peaked at $1.62M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.